Global Patent Index - EP 1064356 A2

EP 1064356 A2 2001-01-03 - CARDIAC-DERIVED STEM CELLS

Title (en)

CARDIAC-DERIVED STEM CELLS

Title (de)

HERZ-DERIVIERTE STAMMZELLEN

Title (fr)

CELLULES SOUCHES D'ORIGINE CARDIAQUE

Publication

EP 1064356 A2 (EN)

Application

EP 99912853 A

Priority

  • US 9906356 W
  • US 7913298 P

Abstract (en)

[origin: WO9949015A2] The invention provides cardiac-derived pluripotent stem cells, which on proliferation and differentiation can produce a variety of cell types including cardiocytes, fibroblasts, smooth muscle cells, skeletal muscle cells, keratinocytes, osteoblasts and chondrocytes. The cells can be used in methods of treating patients suffering from necrotic heart tissue. The stem cells proliferate and differentiate to produce cardiocytes replacing the necrotic tissue. The cells can also be used to screen compounds for activity in promoting proliferation and/or differentiation of cardiac-derived stem cells.

IPC 1-7 (main, further and additional classification)

C12N 5/06; A61K 35/34; C12N 5/08; C12N 5/10; G01N 33/50

IPC 8 full level (invention and additional information)

G01N 33/50 (2006.01); A61K 35/34 (2006.01); A61P 9/00 (2006.01); A61P 43/00 (2006.01); C12N 5/077 (2010.01); A61K 38/00 (2006.01)

CPC (invention and additional information)

C12N 5/0668 (2013.01); C12N 5/0657 (2013.01); A61K 38/00 (2013.01); C12N 2500/90 (2013.01)

Citation (search report)

See references of WO 9949015A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9949015 A2 19990930; WO 9949015 A3 19991216; AU 3112499 A 19991018; CA 2324350 A1 19990930; EP 1064356 A2 20010103; JP 2002507407 A 20020312

INPADOC legal status


2005-04-20 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20041001

2001-01-03 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20001023

2001-01-03 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE